Keregen: Winner of the world’s largest Biotech Start-up Accelerator!

03/06/2015 - 2 minutes

 OneStart 2015, the world’s largest life sciences and health care startup accelerator program has just rewarded Keregen from the UK with €137.8K (£100K) and Ligadon with €134.6K ($150K) for respectively winning OneStart Europe and OneStart Americas.

So, who is this promising European upcomer? Keregen, based in London, develops first-in-class medicines for the prevention and treatment of neurodegenerative diseases and is particularly focused on Parkinson’s. Originally launched at University College London, judges vouched for Keregen’s molecular technology and its potential to slow and even stop the progression of Parkinson’s disease, whilst simultaneously preserving and promoting the quality and longevity of cells

SR One and the Oxbridge Biotech Roundtable (OBR) have partnered to build a program rewarding innovative young entrepreneurs. The project, initially launched back in 2013, received over 630 candidates for the 2015 edition! The interesting thing about this competition lies in the fact that applicants can not be more than 35 years of age.

Of course, with a significant check at the end of the process, the European and American winners came out happiest.

This content is available exclusively to our paying members.

Our members receive the following benefits:

  • Unlock premium articles
  • Download our industry reports
  • Remove all banner ads
  • Access 1,500+ archived posts
  • Support our independent media
Already a member? Sign in
Do you want to remove this advert? Become a member!
Do you want to remove this advert? Become a member!

You might also be interested in the following:

Support Us

Become a Member